PRICE T ROWE ASSOCIATES INC /MD/ - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 1 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$267
-18.8%
39,892
+1.9%
0.00%
Q2 2023$329
-33.3%
39,150
-21.0%
0.00%
Q1 2023$493
+42.9%
49,5870.0%0.00%
Q4 2022$345
-99.8%
49,587
+44.2%
0.00%
Q3 2022$184,000
+1.7%
34,387
-24.1%
0.00%
Q2 2022$181,000
-12.1%
45,310
-2.3%
0.00%
Q1 2022$206,000
+39.2%
46,364
+25.1%
0.00%
Q4 2021$148,000
+51.0%
37,064
+232.0%
0.00%
Q3 2021$98,000
-23.4%
11,164
-0.9%
0.00%
Q2 2021$128,00011,2640.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,031,915$20,253,19221.02%
Perceptive Advisors 11,350,085$75,818,5682.53%
JOHNSON & JOHNSON 394,834$2,637,4910.97%
Joseph P. Lucia & Associates, LLC 28,331$189,2510.13%
WOODSTOCK CORP 137,179$916,3560.12%
Palo Alto Investors LP 160,800$1,074,1440.10%
Affinity Asset Advisors, LLC 44,348$296,2450.08%
Verition Fund Management LLC 935,273$6,247,6240.07%
FOX RUN MANAGEMENT, L.L.C. 33,519$223,9070.07%
TOBIAS FINANCIAL ADVISORS, INC. 34,173$228,2760.06%
View complete list of ALDEYRA THERAPEUTICS INC shareholders